Premium
Siguler Guff & Company, a US-based alternative investment firm, is looking to monetise its bet on an Indian medical devices manufacturer through a secondary transaction, two people privy to the development told VCCircle. New York-headquartered Siguler Guff, which is raising an emerging markets fund with an India mandate, is planning to ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.